Hepatitis C

Background of hepatitis C virus (HCV)

Type  Clinical features 
Prevalence 
  • High prevalence (> 2%) 
    • China 
    • Eastern Mediterranean 
    • Egypt 
    • India 
    • Pakistan 
  • Moderate prevalence (1-2%) 
    • Africa 
    • Europe 
  • Low prevalence ( < 1%) 
    • North & South America 
    • Southeast Asia 
    • Western Pacific countries 
Virology 
  • Single stranded RNA virus from family Flaviviridae  
  • Viral replication cycle 
    • Viral RNA translated into polyprotein by host cells after viral entry 
    • Viral protease complex NS3 and NS4A proteins work together to cleave polyprotein into mature viral proteins 
    • NS5A and NS5B help modulate further viral replication and release viral particle from host cell 
  • Genotypes 
    • Genotype 1  
      • 60-75% of patients in US, Latin America, and Europe 
      • Subtypes include 1a and 1b 
    • Genotype 2  
      • ~15% of patients) in US, Latin America, and Europe 
      • Subtypes include 2a and 2b 
    • Genotype 3  
      • More common in India, Far East, and Australia 
    • Genotype 4  
      • Most common in Africa and Middle East 
    • Genotype 5  
      • Most common in South Africa 
    • Genotype 6  
      • Most common in Hong Kong and Vietnam 
Possible modes of viral transmission
  • Blood transfusion 
  • Mother to child in utero, during chilbirth, or after childbirth 
  • Organ transplant from infected donors 
  • Sexual transmission 
  • Percutaneous innoculation by contaminated equipment 
    • Accidental needle stick 
    • Acupuncture 
    • Body piercing 
    • Syringes and needles by IV drug use 
    • Tattooing 
(Next Lesson) Clinical presentation of hepatitis C
Back to Hepatitis C

No Comments

Comments are closed.